94 related articles for article (PubMed ID: 25455182)
1. Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist.
Ohmi M; Shishido Y; Inoue T; Ando K; Fujiuchi A; Yamada A; Watanabe S; Kawamura K
Bioorg Med Chem Lett; 2014 Dec; 24(23):5364-8. PubMed ID: 25455182
[TBL] [Abstract][Full Text] [Related]
2. Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists.
Tamayo NA; Bo Y; Gore V; Ma V; Nishimura N; Tang P; Deng H; Klionsky L; Lehto SG; Wang W; Youngblood B; Chen J; Correll TL; Bartberger MD; Gavva NR; Norman MH
J Med Chem; 2012 Feb; 55(4):1593-611. PubMed ID: 22329507
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and optimization of novel α-phenylglycinamides as selective TRPM8 antagonists.
Kobayashi JI; Hirasawa H; Ozawa T; Ozawa T; Takeda H; Fujimori Y; Nakanishi O; Kamada N; Ikeda T
Bioorg Med Chem; 2017 Jan; 25(2):727-742. PubMed ID: 27964995
[TBL] [Abstract][Full Text] [Related]
4. Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.
Beccari AR; Gemei M; Lo Monte M; Menegatti N; Fanton M; Pedretti A; Bovolenta S; Nucci C; Molteni A; Rossignoli A; Brandolini L; Taddei A; Za L; Liberati C; Vistoli G
Sci Rep; 2017 Sep; 7(1):10999. PubMed ID: 28887460
[TBL] [Abstract][Full Text] [Related]
5. Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
Parks DJ; Parsons WH; Colburn RW; Meegalla SK; Ballentine SK; Illig CR; Qin N; Liu Y; Hutchinson TL; Lubin ML; Stone DJ; Baker JF; Schneider CR; Ma J; Damiano BP; Flores CM; Player MR
J Med Chem; 2011 Jan; 54(1):233-47. PubMed ID: 21128593
[TBL] [Abstract][Full Text] [Related]
6. Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists.
Zhu B; Xia M; Xu X; Ludovici DW; Tennakoon M; Youngman MA; Matthews JM; Dax SL; Colburn RW; Qin N; Hutchinson TL; Lubin ML; Brandt MR; Stone DJ; Flores CM; Macielag MJ
Bioorg Med Chem Lett; 2013 Apr; 23(7):2234-7. PubMed ID: 23411075
[TBL] [Abstract][Full Text] [Related]
7. The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
Matthews JM; Qin N; Colburn RW; Dax SL; Hawkins M; McNally JJ; Reany L; Youngman MA; Baker J; Hutchinson T; Liu Y; Lubin ML; Neeper M; Brandt MR; Stone DJ; Flores CM
Bioorg Med Chem Lett; 2012 Apr; 22(8):2922-6. PubMed ID: 22421018
[TBL] [Abstract][Full Text] [Related]
8. Identification of N-acyl-N-indanyl-α-phenylglycinamides as selective TRPM8 antagonists designed to mitigate the risk of adverse effects.
Kobayashi JI; Hirasawa H; Fujimori Y; Nakanishi O; Kamada N; Ikeda T; Yamamoto A; Kanbe H
Bioorg Med Chem; 2021 Jan; 30():115903. PubMed ID: 33333445
[TBL] [Abstract][Full Text] [Related]
9. Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines.
Okamoto Y; Ohkubo T; Ikebe T; Yamazaki J
Int J Oncol; 2012 May; 40(5):1431-40. PubMed ID: 22267123
[TBL] [Abstract][Full Text] [Related]
10. (-)-Menthylamine derivatives as potent and selective antagonists of transient receptor potential melastatin type-8 (TRPM8) channels.
Ortar G; De Petrocellis L; Morera L; Moriello AS; Orlando P; Morera E; Nalli M; Di Marzo V
Bioorg Med Chem Lett; 2010 May; 20(9):2729-32. PubMed ID: 20378345
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of TRPM8-induced gene transcription.
Thiel G; Backes TM; Welck J; Steinhausen S; Fischer AL; Langfermann DS; Ulrich M; Wissenbach U; Rössler OG
Biochem Pharmacol; 2019 Dec; 170():113678. PubMed ID: 31654626
[TBL] [Abstract][Full Text] [Related]
12. Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonists.
Horne DB; Tamayo NA; Bartberger MD; Bo Y; Clarine J; Davis CD; Gore VK; Kaller MR; Lehto SG; Ma VV; Nishimura N; Nguyen TT; Tang P; Wang W; Youngblood BD; Zhang M; Gavva NR; Monenschein H; Norman MH
J Med Chem; 2014 Apr; 57(7):2989-3004. PubMed ID: 24597733
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic Activity.
Bertamino A; Iraci N; Ostacolo C; Ambrosino P; Musella S; Di Sarno V; Ciaglia T; Pepe G; Sala M; Soldovieri MV; Mosca I; Gonzalez-Rodriguez S; Fernandez-Carvajal A; Ferrer-Montiel A; Novellino E; Taglialatela M; Campiglia P; Gomez-Monterrey I
J Med Chem; 2018 Jul; 61(14):6140-6152. PubMed ID: 29939028
[TBL] [Abstract][Full Text] [Related]
14. AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia.
Lehto SG; Weyer AD; Zhang M; Youngblood BD; Wang J; Wang W; Kerstein PC; Davis C; Wild KD; Stucky CL; Gavva NR
Naunyn Schmiedebergs Arch Pharmacol; 2015 Apr; 388(4):465-76. PubMed ID: 25662185
[TBL] [Abstract][Full Text] [Related]
15. TRPM8 biology and medicinal chemistry.
DeFalco J; Duncton MA; Emerling D
Curr Top Med Chem; 2011; 11(17):2237-52. PubMed ID: 21671871
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
Chaudhari SS; Kadam AB; Khairatkar-Joshi N; Mukhopadhyay I; Karnik PV; Raghuram A; Rao SS; Vaiyapuri TS; Wale DP; Bhosale VM; Gudi GS; Sangana RR; Thomas A
Bioorg Med Chem; 2013 Nov; 21(21):6542-53. PubMed ID: 24055075
[TBL] [Abstract][Full Text] [Related]
17. Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies.
Journigan VB; Feng Z; Rahman S; Wang Y; Amin ARMR; Heffner CE; Bachtel N; Wang S; Gonzalez-Rodriguez S; Fernández-Carvajal A; Fernández-Ballester G; Hilton JK; Van Horn WD; Ferrer-Montiel A; Xie XQ; Rahman T
ACS Chem Neurosci; 2020 Feb; 11(3):268-290. PubMed ID: 31850745
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of the prototypical TRPM8 agonist icilin.
De Petrocellis L; Ortar G; Schiano Moriello A; Serum EM; Rusterholz DB
Bioorg Med Chem Lett; 2015 Jun; 25(11):2285-90. PubMed ID: 25935641
[TBL] [Abstract][Full Text] [Related]
19. Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.
Terada Y; Kitajima M; Taguchi F; Takayama H; Horie S; Watanabe T
J Nat Prod; 2014 Aug; 77(8):1831-8. PubMed ID: 25052206
[TBL] [Abstract][Full Text] [Related]
20. Camphor activates and sensitizes transient receptor potential melastatin 8 (TRPM8) to cooling and icilin.
Selescu T; Ciobanu AC; Dobre C; Reid G; Babes A
Chem Senses; 2013 Sep; 38(7):563-75. PubMed ID: 23828908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
